The product liability litigation will concentrate on core medical and scientific issues and the alleged failure to warn about serious gastrointestinal injuries and other serious complications tied to the diabetes medication manufactured by Novo Nordisk
Shima Hadidchi, MD specialized in medical weight loss and stays current with all FDA-approved GLP-1 treatments
But its often the small , everyday actions that make the biggest difference
Adjuvant glucose-like peptide 1 receptor agonist therapy for suboptimal weight loss after bariatric surgery: a systematic review
Timing becomes even more critical if you take oral semaglutide
If stopping the medication leads to gradual regain, and that regain affects your health (blood pressure, blood sugar, joint pain, sleep apnoea), the comparison isnt medication cost vs no cost: its medication cost vs the cost of treating regained weight and its consequences